Tumor Inhibiting and Immunoloregulation Effects of Mylabris Mixture on H22 Cancer-Bearing Mice
A-Gao Zhou,Yong Zhang,De-Yun Kong,Yin Wang,Hui-Zhen Zhang,Shu-Jun Wang,Gang Kui,Sheng Hong,Hai-Liang Ge,Qiu-Hua Ren,Xu-Ming Mao,Jia-Rong Dong
DOI: https://doi.org/10.3736/jcim20060513
2006-01-01
Journal of Chinese Integrative Medicine
Abstract:OBJECTIVE:To investigate the mechanisms of tumor inhibiting and immunoloregulation of Mylabris Mixture on H22 cancer-bearing mice.METHODS:H22 cancer-bearing mice were chosen to observe the effects of tumor inhibiting and detect the proliferation function of T lymphocytes, the toxicity function of NK cells, the changes of T lymphocytes and the contents of interferon-gamma and interleukin-4.RESULTS:Mylabris Mixture could obviously inhibit the growth of H22 cancer in mice, and the tumor inhibition rat was 65.76%. The stimulation index of T lymphocyte transformation and percentage of NK cells in Mylabris Mixture-treated group were obviously higher than those in the normal control group. The subpopulation proportion of T lymphocytes in Mylabris Mixture-treated group was changed more than the normal control group. The production of interferon-gamma and interleukin-4 by T lymphocytes obviously increased in Mylabris Mixture-treated group (P<0.05, P<0.001).CONCLUSION:Mylabris Mixture has the effect of inhibiting the growth of tumor constitution, and regulating immunological function on mice with tumor. Its mechanisms include the reinforcement of T lymphocyte immune function, NK cell killing function and humoral immune function.